title: Change in blood pressure predicts regression of cardiac hypertrophy in patients of African ancestry receiving agents influencing the renin-angiotensin system.
authors.forename: E N
authors.initials: EN
authors.lastname: Libhaber
authors.forename: G R
authors.initials: GR
authors.lastname: Norton
authors.forename: C D
authors.initials: CD
authors.lastname: Libhaber
authors.forename: G P
authors.initials: GP
authors.lastname: Candy
authors.forename: A J
authors.initials: AJ
authors.lastname: Woodiwiss
authors.forename: K
authors.initials: K
authors.lastname: Sliwa
authors.forename: M R
authors.initials: MR
authors.lastname: Essop
authors.forename: P
authors.initials: P
authors.lastname: Sareli
mesh_terms: D000328:Adult; D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D044383:Black People; D001794:Blood Pressure / Q000502:physiology*; D006332:Cardiomegaly / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology*; D004232:Diuretics / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012074:Remission Induction
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics